Company Description
ImClone Systems has got it in for the big "C." The biotechnology firm is focused on developing monoclonal antibody therapies that treat various...
Key ImClone Financials
| Company Type | Public - NASDAQ (GS): IMCL Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $590.8 |
| 2007 Employees | 1,128 |
More ImClone Financials (11 pages)
Latest ImClone Jobs jobs by Indeed
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about ImClone's competition across multiple industries
Top ImClone Competitors
Sponsored Links
The Business Directory
ImClone Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Carl C. Icahn | Network | E-mail |
| VP Business Development | John Zawad | Network | E-mail |
| CEO and Director | John H. Johnson | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current ImClone News
- BioWorld Today September 5, 2008 [BioWorld Today] (05 Sep 2008 00:01:00 EDT)
- BioWorld Today September 4, 2008 [BioWorld Today] (04 Sep 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (03 Sep 2008 23:00:00 EDT)
Sponsored Opportunity
